We are so excited to announce that ARU under the direction of Dr. Hodis received funds from NHI for the clinical trial APPT (Advancing Postmenopausal Preventive Therapy).
The goal of the project is to conduct a double-blinded, placebo-controlled trial to determine the effects of tissue selective estrogen complex (TSEC) therapy on the progression of subclinical atherosclerosis in healthy postmenopausal women.
For more information and enquiries about the coming clinical trial please email [email protected] or fill the form below.
